Updated results of single-agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).

被引：9
|
作者：
Grommes, Christian
Gavrilovic, Igor T.
Kaley, Thomas Joseph
Nolan, Craig
Omuro, Antonio Marcilio Padula
Wolfe, Julia
Pentsova, Elena
Hatzoglou, Vaios
Mellinghoff, Ingo K.
DeAngelis, Lisa Marie
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.7515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7515
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Successful Consolidation/Maintenance Therapy with Single Agent Ibrutinib for Primary CNS Lymphoma after Initial Induction Therapy
    Du, Steven
    Bota, Daniela
    Kong, Xiao-Tang
    NEUROLOGY INTERNATIONAL, 2022, 14 (03): : 574 - 580
  • [32] Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results
    Wang, Michael L.
    Blum, Kristie A.
    Martin, Peter
    Goy, Andre
    Auer, Rebecca
    Kahl, Brad S.
    Jurczak, Wojciech
    Advani, Ranjana H.
    Romaguera, Jorge E.
    Williams, Michael E.
    Barrientos, Jacqueline C.
    Chmielowska, Ewa
    Radford, John
    Stilgenbauer, Stephan
    Dreyling, Martin
    Jedrzejczak, Wieslaw Wiktor
    Johnson, Peter
    Spurgeon, Stephen E.
    Zhang, Liang
    Baher, Linda
    Cheng, Mei
    Lee, Dana
    Beaupre, Darrin M.
    Rule, Simon
    BLOOD, 2015, 126 (06) : 739 - 745
  • [33] SINGLE-AGENT LENALIDOMIDE FOR THE TREATMENT OF RELAPSED OR REFRACTORY AGGRESSIVE LYMPHOMA PATIENTS
    Puccini, B.
    Chitarrelli, I.
    Antognoli, G.
    Fabbri, A.
    Rigacci, L.
    Lenoci, M. P.
    Lauria, F.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 288 - 288
  • [34] Updated results from NABTT CNS consortium studies in primary CNS lymphoma.
    Batchelo, T
    Grossman, S
    Carson, K
    Fisher, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 111S - 111S
  • [35] Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma
    Hottinger, Andreas F.
    DeAngelis, Lisa M.
    Yahalom, Joachim
    Abrey, Lauren E.
    NEUROLOGY, 2007, 69 (11) : 1178 - 1182
  • [36] SINGLE-AGENT IBRUTINIB IN RITUXIMAB-REFRACTORY PATIENTS WITH WALDENSTROM'S MACROGLOBULINEMIA (WM): UPDATED RESULTS FROM A MULTICENTER, OPEN-LABEL PHASE 3 SUBSTUDY (INNOVATETM)
    Dimopoulos, M.
    Trotman, J.
    Tedeschi, A.
    Matous, J. V.
    Macdonald, D.
    Tam, C.
    Tournilhac, O.
    Ma, S.
    Oriol, A.
    Heffner, L.
    Shustik, C.
    Garcia-Sanz, R.
    Cornell, R. F.
    Fernandez de Larrea, C.
    Castillo, J. J.
    Granell, M.
    Kyrtsonis, M. C.
    Leblond, V.
    Symeonidis, A.
    Singh, P.
    Li, J.
    Graef, T.
    Bilotti, E.
    Treon, S.
    Buske, C.
    HAEMATOLOGICA, 2016, 101 : 256 - 257
  • [37] Expanding the Indications for Ibrutinib: Complete Remission Obtained By Induction with Ibrutinib Followed By Consolidative Ahsct in Refractory Primary CNS Lymphoma
    Brothers, Cassidy
    BLOOD, 2019, 134
  • [38] Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma
    Witzig, Thomas E.
    Vose, Julie
    Zinzani, Pier Luigi
    Habermann, Thomas Matthew
    Tuscano, Joseph M.
    Sinha, Rajni
    Williams, Michael E.
    Drach, Johannes W.
    Ramchandren, Rod
    Besisik, Sevgi Kalayoglu
    Zhang, Lei
    Cicero, Sherri
    Fu, Tommy
    Goy, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Ibrutinib Monotherapy in Relapse or Refractory Primary CNS Lymphoma (PCNSL) and Primary Vitreo-Retinal Lymphoma (PVRL). Result of the Interim Analysis of the iLOC Phase II Study from the Lysa and the French LOC Network
    Choquet, Sylvain
    Houillier, Caroline
    Bijou, Fontanet
    Houot, Roch
    Boyle, Eileen
    Gressin, Remy
    Nicolas-Virelizier, Emmanuelle
    Barrie, Maryline
    Molucon-Chabrot, Cecile
    Blonski, Marie
    El Yamani, Abderrazak
    Lelez, Marie-Laure
    Clavert, Aline
    Coisy, Solene
    de la Bretonniere, Marjan Ertault
    Touitou, Valerie
    Cassoux, Nathalie
    Boussetta, Sami
    Broussais, Florence
    Gelas-Dore, Benedicte
    Barzic, Noelie
    Ghesquieres, Herve
    Hoang-Xuan, Khe
    Soussain, Carole
    BLOOD, 2016, 128 (22)
  • [40] Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL)
    Malfona, Francesco
    Testi, Anna Maria
    Moleti, Maria Luisa
    Petrucci, Luigi
    Martelli, Maurizio
    Di Rocco, Alice
    Leccisotti, Lucia
    LEUKEMIA & LYMPHOMA, 2022, 63 (02) : 483 - 486
12345